Volume 12 - Issue 8 - August, 2004
Clinical and Industry News
- Thu, 6/19/08 - 1:59pm
- 1 Comments
Boston Scientific Launches Cardiovascular Patch with Low Porosity
Boston Scientific Corporation announced the worldwide launch of its Hemashield Platinum Finesse Ultra-Thin Knitted Cardiovascular Patch for vascular or cardiac patch grafting.
With 50% improved porosity over the Company’s existing Hemashield Finesse® Patch, the Hemashield Platinum Finesse Patch provides excellent hemostasis, or a reduced amount of bleeding after closing the incision. The patch is tapered and pre-trimmed for greater efficiency and it conforms to the host vessel for improved handling. It is de
Letter to the Editor
- Thu, 6/19/08 - 1:59pm
- 0 Comments
Robert J. Rogers, MD, wrote Cath Lab Digest in reference to the following text from the June 2004 cath lab design article, At the Heart:
The first diagram illustrates a spatial width of 19 feet, extremely tight given that an anesthesiologist with a cart connected to gases may tend to a patient.
Today, that space can be as great as 28 feet wide, an increase not only to accommodate a sizable anesthesiology cart, but to allow a growing number of staff to administer to the patient from all sides.
Dear Editor,
I do enjoy reading Cath Lab Digest, and was very interested i
Cath Lab Digest Email Discussion Group
- Thu, 6/19/08 - 1:59pm
- 0 Comments
Topic Under Discussion:
How do you charge for two stent lesions?
My understanding is that you cannot charge for an additional vessel if lesions are in the same vessel or if it is in the same system. For example, we do not charge for additional lesions even if one is in the LAD and the other one is in the CFX. However, if the additional lesion is in the RCA, then we do charge. I ask because APC’s Weekly Monitor on June 18th makes it sound like we can charge for additional lesions.
Thank you,
Larry Sneed, BS, RCP
Coordinator, Cath Lab
Alamance Regional Medical
The Advance of Carotid Stenting
- Thu, 6/19/08 - 1:59pm
- 0 Comments
How frequently are you performing carotid stenting cases?
At the Cleveland Clinic, we typically do five to ten per week.
What are your criteria for patient selection?
Currently we are treating patients who are at increased surgical risk for carotid endarterectomy. Increased risk includes severe heart disease, previous carotid surgery, restenosis and advanced age.
How do the risks of carotid stenting differ from a carotid endarterectomy?
The SAPPHIRE study showed stenting had roughly half the complication rate of carotid surgery in patients that were at
Peripherals, and announcing a new publication
- Thu, 6/19/08 - 1:59pm
- 0 Comments
Riding the cath lab range used to mean seeing only the coronaries, but many cath labs across the U.S. are moving (or have already moved) into peripheral vascular work.
One example is our spotlight this month, Community Medical Center in Scranton, Pennsylvania, although this lab is no newcomer, and has been performing peripheral work for quite some time. Manager Thomas Gaylets notes, We have been performing these procedures for 7 years, with staff being trained on-the-job with an experienced radiological technologist.
Making a plea for increased staff education on peripherals is Cath
Professional Perspective: Cartoid Stenting Commentary
- Thu, 6/19/08 - 1:59pm
- 0 Comments
Now let’s jump to the latter half of the 1990s: percutaneous coronary interventions are routine and with the development of stenting, become safer, more effective therapy. The availability of hundreds of guide catheter curves, steerable guidewires, low-profile balloons, stents, GP IIb/IIIa agents and other adjunctive pharmacologic therapies not only have made coronary interventions easier to perform, but relatively benign as well (with the exception of hemodynamically unstable MI or cardiogenic shock). If this procedure is so effective in treating coronary artery disease, can we apply this
Cartoid Endarterectomy: An Established Standard for Acute and Chronic Prevention of Stroke
- Thu, 6/19/08 - 1:59pm
- 0 Comments
It is important to note that the proof of carotid endarterectomy had little to do with acute results but rather the outcome over a period of years following the procedure.6 While the surgical techniques that are the foundation of carotid endarterectomy have changed little, the patient selection, intraprocedural cerebral monitoring and post-procedural follow-up and care have been greatly refined.
While the debate about the rates of acute success with interventional techniques rages on, we should not forget the lessons amply demonstrated throughout the lengthy and rigorous developm
Community Medical Center
- Thu, 6/19/08 - 1:59pm
- 0 Comments
We have 17 staff members, comprised of RNs and RTs. We also have one medical secretary and a scheduling coordinator. Our staff experience ranges from 20 years to two months. Our Cardiac Cath Lab Director is Dr. Kevin Olsen. We established our heart program seven years ago and are currently in the process of expanding into another cardiac room, will be finished in early August.
What type of procedures are performed at your facility?
We perform PCIs, diagnostic caths, EP procedures (pacers and defibs), and also peripheral procedures. Peripheral procedures include renal, iliac, su
Angiographic Demonstration of Coronary Dethrombosis with Eptifibatide
- Thu, 6/19/08 - 1:59pm
- 0 Comments
Coronary thrombus dissolution after intracoronary1 or intravenous2,3 abciximab administration has been angiographically proven in previous clinical reports. The present report shows dissolution of coronary thrombi with eptifibatide, a pharmacologically different antagonist of the GPIIb/IIIa platelet receptor, in conjunction with alteplase (case #1) or alone (case #2).
Case #1. The first case is that of a 55-year-old gentleman with no previous cardiovascular history. He was seen in the Emergency Room because of sudden chest pain with ST-segment elevation on the
Advances in Guidewire Technology
- Thu, 6/19/08 - 1:59pm
- 0 Comments
What characteristics do you find important in regard to guidewire construction?
Even with the many changes in angioplasty, the one thing that still hasn’t changed in terms of guidewire characteristics is the ability to torque and maneuver your wire through the most tortuous lesions. For straightforward, sort of slam-dunk lesions, you can really use just about any wire, but I still look at torquability through the more circuitous vessels as one of my preferred characteristics on the wire.
I was very pleased after using some of the AVD Asahi wires. Specifically we’ve used t
- « Previous
- | Page 1 of 2 |
- Next »
